NCT06524830
ClinicalTrials.gov
- Trial ID
- T-ctgov-NCT06524830
- Registry
- ClinicalTrials.gov
- NCT number
- NCT06524830
- Asset
- VLS-01
- Sponsor, as registered
- atai Therapeutics, Inc.
- Phase
- PHASE2
- Indication
- Treatment Resistant Depression
- Status
- RECRUITING
- Start date
- 2024-12-30
- Primary completion
- 2026-08-01
- Registered countries
- Australia, Canada, United Kingdom, United States
- Sites
- 48
The sponsor's registered location list, which states intent rather than approval.
clinicaltrials.govctgov registryverified 2026-08-31
Notes on the record
Fields read from the ClinicalTrials.gov v2 API record. countries is the distinct country list across all registered locations; site_count is the number of location entries, which counts a country once per site, not once per country.
Company
Through VLS-01: atai Therapeutics
Cited in
Issues quoting NCT06524830 in their own text.